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Abstract
Introduction: Type I thyroplasty is the treatment of choice for unilateral vocal cord palsy with 
no spontaneous recovery. 
Objectives: To compare the use of silastic implant with titanium vocal fold medializing implant 
(TVFMI®) in type I thyroplasty for unilateral vocal cord palsy with respect to subjective and 
objective improvement in voice, endoscopic changes in vocal cords, surgical time, and cost 
effectiveness.
Methodology: This was a prospective study conducted on 40 patients with unilateral vocal cord 
paralysis who underwent type I thyroplasty with either silastic implant or TVFMI®. Pre-operative 
and four-week post-operative assessment and statistical comparison were performed by vide-
olaryngoscopy, stroboscopy, perceptual assessment (GRBAS), subjective (voice handicap index) 
analysis of voice, and computer-assisted acoustic and electroglottographic assessment. The 
duration of surgery and cost of implant were also recorded. 
Results: Although both implants showed improvement in quality of voice following thyroplasty, 
TVFMI® presents slightly better results in objective voice analysis. The surgery time for TVFMI® 
insertion was shorter, but the costs were higher.
Conclusion: TVFMI® may be preferred for medialization thyroplasty as it presents better voice 
results and demands less surgical time; however, it is costlier than silastic implant.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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Comparação do uso de implante de Silastic® com titânio pré-fabricado na tireoplastia tipo I
Resumo
Introdução: A tireoplastia tipo I é o tratamento de escolha nas paralisias unilaterais das pregas 
vocais que não se recuperam espontaneamente. 
Objetivos: Comparar o uso de implante de Silastic® com o uso de titânio pré-fabricado TVFMI® 
(Titanium Vocal Fold Medializing Implant) na tireoplastia tipo I para o tratamento da paralisia 
unilateral das pregas vocais com relação à melhora subjetiva e objetiva da voz, às alterações 
endoscópicas nas pregas vocais, ao tempo de cirurgia e à relação custo-benefício.
Método: Trata-se de um estudo prospectivo com 40 pacientes portadores de paralisia unilateral 
das pregas vocais submetidos à tireoplastia tipo I com implante de silastic® ou TVFMI®. A aval-
iação e comparação estatística foram realizadas antes e quatro semanas depois da cirurgia por 
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Introduction 
The important functions of the human larynx are the protec-
tion of lower airways and phonation. Unilateral vocal cord 
paralysis is the most common neurogenic disorder affecting 
the larynx.1 Vocal fold paralysis occurs due to the involve-
ment of the vagus or its recurrent laryngeal nerve between 
the jugular foramen and its entrance into larynx. 90% of 
paralyses are due to lesions affecting the nerves along their 
peripherally located segments. Only 15% are proximal to the 
jugular foramen.2
The surgical treatment of choice in such cases is type 
I thyroplasty or medialization thyroplasty with or without 
arytenoid adduction. Based on the principles set forth by Is-
shiki, several modifications have been introduced. Over the 
years, the shape of silastic implants has been modified, and 
different materials have been used, such as Gore-tex and 
VoCom, among others. The titanium vocal fold medializing 
implant (TVFMI®) is one of these modifications. This implant 
is intended to save time and provide good vocal cord me-
dialization.
In this study, the voice improvements after type I thyro-
plasty using TVFMI® and conventional Silastic® implants 
were compared. The surgical time necessary and the costs 
of these implants were also assessed.
Materials and methods 
This was a prospective study conducted in 40 patients with 
unilateral vocal cord paralysis at a tertiary care center af-
ter approval from the hospital’s ethics committee (protocol 
approval No. -3/30, September of 2010). 
The patients included in the study had unilateral vocal 
cord paralysis for more than six months and underwent type 
I thyroplasty with either Silastic® implant or TVFMI®. Revi-
sion thyroplasty and larynx malignancy cases were excluded 
from the study.
The patients of unilateral vocal cord paralysis were ran-
domly divided into two groups to undergo type I thyroplas-
ty using silastic implant and TVFMI®. TVFMI® is  made by 
Gerhard Friedrich of Austria. It is produced by Heinz Kurz 
GmbH Medizintechnik Tuebinger Strasse 3 72144 Dusslingen, 
Germany. The implants used came from lot 2092720. Demo-
graphic data, including age and gender, were recorded, as 
well as the suspected etiology of the vocal cord paralysis. 
The patients then underwent a thorough general physical and 
ENT examination. The patients underwent objective assess-
ment of voice using the voice handicap index (VHI), percep-
tual assessment of voice using GRBAS, videolaryngoscopy, and 
stroboscopic assessment of vocal cord function. Acoustic and 
electroglottographic voice assessments were also performed. 
Videolaryngoscopic examination was performed along 
with stroboscopy (endostrobe with xenon light using 90 de-
gree Hopkins laryngoscope). The examinations assessed the 
mobility of the cords, presence or absence of glottic gap at 
the time of adduction, and mucosal wave if present. The 
patients were given a VHI form to be completed by them. 
The voice of the patient was subjectively graded through 
the GRBAS scale and by a four-point Likert scale.
The patients also underwent voice analysis and elec-
troglottography, which were performed using Dr. Speech 
software (Tiger DRS, Inc). The parameters considered for 
comparison in acoustic analysis (figure) were: maximum 
phonation time (MPT), fundamental frequency (F0), shim-
mer, jitter, harmonic to noise ratio (HNR), and normalized 
noise energy (NNE). 
For EGG, the evaluated parameters were F0, jitter, 
shimmer, NNE, HNR, contact quotient (CQ), and contact 
quotient perturbation (CQP). 
Following this analysis, the patients who qualified for 
surgery according to the treatment protocol (unilateral per-
manent RLN palsy with no improvement/compensation over 
six months) were considered for surgery. After the patients 
signed the informed consent, they underwent a standard 
type I thyroplasty with silastic implant (type B) (Fig. 1) or 
TVFMI® (Fig. 2). 
The extent of medialization was noted by asking the pa-
tient to vocalize and also by fiber-optic laryngoscopic exa-
mination to observe the position of the vocal cords. In cases 
of TVFMI®, two types of implants were used: 15 mm for ma-
les and 13 mm for females. 
The videolaryngoscopy, stroboscopy, VHI completion, 
GRBAS voice analysis, acoustic analysis, and electroglot-
tography were performed both pre-operatively and at four 
weeks post-operatively. These parameters were recorded,-
transferred into a MS Office Excel worksheet, and tabulated.
At the end of the study, the data were analysed using 
SPSS, version 17. Paired Student’s t-test was used for com-
paring the pre- and post-operative VHI values. Pre- and 
meio de videolaringoscopia, estroboscopia, análise perceptiva (escala GRBAS-Grade, Rough-
ness, Breathiness, Asthenia, Strain) e subjetiva (IDV-índice de desvantagem vocal) da voz e 
avaliação eletroglotográfica e avaliação acústica computadorizada. Também foram observados 
o tempo de cirurgia e o custo do implante. 
Resultados: Embora os dois implantes mostrem melhora na qualidade da voz após a tireoplastia, 
o TVFMI® teve um resultado ligeiramente melhor na análise objetiva da voz. O TVFMI® levou 
menos tempo de cirurgia para ser inserido, porém foi mais caro. 
Conclusão: O TVFMI® poderá ser preferencial na tireoplastia de medialização, já que possui 
melhores resultados vocais e leva menos tempo de cirurgia, porém é mais caro que o implante 
de Silastic®. 
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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post-operative values of GRBAS  were compared separa-
tely using paired Student’s t-test. Individual parameters of 
acoustic analysis and EGG were also compared pre- and pos-
t-operatively, and the p-values were calculated. Student’s 
t-test for independent variables was used to compare the 
improvement in parameters (VHI, GRBAS, acoustic analysis, 
EGG) following the type I thyroplasty with silastic implant 
or TVFMI®. p-values less than 0.05 were considered to be 
significant (95% confidence interval).
Results
The study included 40 patients; 31 males (77%) and nine fe-
males (23%). The age and gender distribution of vocal cord 
paralysis varies according to the aetiology of the paralysis. 
In the present study, 26 patients were less than 50 years of 
age and 14 were over 50 years.
30 patients were of left vocal cord (75%) and 10 of right 
vocal cord (25%). The ratio of left to right vocal cord palsy 
is 3:1. 
Out of these 40 patients, ten (25%) had a skull base/
head and neck tumor. These tumors included glomus jugu-
lare, vestibular schwannoma, and nasopharyngeal carci-
noma. Five patients (12%) had developed vocal cord palsy 
following surgery (cardiothoracic); Four patients (10%) hade 
inflammatory pathologies (mediastinal lymphadenopathy, 
TB); and three patients (8%) had vocal cord palsy due to 
non-surgical trauma (fish bone injury, splinter injury). In the 
remaining 18 patients (45%), no cause could be identified, 
and they were said to have idiopathic vocal cord palsy.
Out of the 40 patients, 20 underwent type I thyroplasty 
with silastic implant and the remaining 20 with TVFMI®.
Surgery duration varied according to the type of implant 
being inserted. In cases where conventional silastic implant 
was used, average surgery duration was 85.05 min. In ca-
ses where TVFMI® was inserted, surgery duration was much 
shorter, 49.5 minutes.
Each TVFMI® implant cost $330. In cases where TVFMI® 
was inserted, an additional instrument, the moulding pliers, 
were required. They were a one-time investment of $215. 
The cost of the silastic block used in each surgery was $38. 
Videolaryngoscopic and stroboscopic assessment de-
monstrated a reduction in glottic gap at the time of ad-
duction in all cases except for one, with apposition of both 
vocal cords in the mid-line. There was only one case who 
underwent medialization with silastic implant and did not 
achieve complete closure of glottic gap. Mucosal wave pat-
tern was not observed in any of the cases pre-operatively; 
post-operatively, it was present in 14 and 16 patients un-
dergoing insertion of silastic implant and TVFMI®, respec-
tively.
Table 1 shows the pre-operative and four weeks post-
-operative mean values of various parameters (VHI, GRBAS, 
acoustic analysism and electroglottography) studied and 
comparison of improvement between silastic implants and 
TVFMI®.
Discussion 
Unilateral vocal cord paralysis is generally observed on left 
side, with the ratio of left to right ranging from 3 to 4:1.2 
Unilateral vocal cord paralysis can present as hoarse voi-
ce, vocal fatigue, dysphagia, decreased pitch, decreased 
loudness, and aspiration. The severity of these symptoms 
depends on the position of the paralysed cord.3 Various te-
chniques have been developed to reduce the glottic gap, 
such as injection thyroplasty and medialization thyroplasty. 
Payr described an external medialization technique in 1915. 
In 1978, Isshiki revolutionized the surgical treatment for 
unilateral vocal cord paralysis by using silastic implant for 
medialization of the paralysed cord.4,5 Based on the basic 
principles given by Isshiki, several modifications have been 
introduced. Over the years, the shape of silastic implant has 
been modified, and different materials were used, such as 
Gore-tex, Vo Com, and titanium, among others.  Currently, 
individually-fitted implants based on computed tomogra-
phic (CT) images have been developed for use in mediali-
zation thyroplasty.6 
As in other studies,2 the present study also observed 
that most of the cases were of unilateral vocal cord palsy; 
25% were due to malignancies of head and neck, followed 
by surgical trauma, 12%. These are comparable to the 
documented percentages in other studies; patients with 
malignancies constitute 25% of the cases with unilateral 
vocal cord palsy, the same as that of the present study. 
Non-surgical trauma has been shown to contribute 15% 
of the cases, which is also similar to the present study. 
Literature reports inflammatory causes as responsible for 
5% of cases; in the present study,  this rate was 10%. This 
was perhaps due to the higher number of chronic infec-
tive diseases observed in the Indian study. 8% of patients 
were of non-surgical trauma in the present study. In 45%, 
no cause could be identified, and they were labelled as 
idiopathic; this high percentage could again be due to 
higher number of infective (viral) pathologies in the pre-
sent study.
The average surgery duration was 85.05 minutes for si-
lastic implant and 49.5 minutes for TVFMI®. One study re-
ported surgery durations of 65 minutes for silastic implant 
Figure 1 A, Carved-out type B silastic implant. B, Silastic 
implant placed in cartilage window.
Figure 2 A, Titanium vocal fold medializing implant (TVFMI®). 
B, TVFMI® placed in the cartilage window.
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Table 1 Pre-operative ansd post-operative mean values of various parameters studied, and comparison of improvement between 
silastic implants and titanium vocal fold medializing implant (TVFMI®) (n = 40).
S. N Parameter
SILASTIC TVFMI®
COMPARISON BETWEEN 
SILASTIC & TVFMI®
Pre-
operative 
mean value
Post-
operative 
mean value
p-value
Pre-
operative 
mean value
Post-
operative 
mean value
p-value Difference between silastic implant / TVFMI®  
1 VHI 84.7 23.4 0.000 83.8 23.05 0.000 No statistical difference
2 G 1.75 0.9 0.001 2 0.8 0.000 No statistical difference
3 R 0.75 0.35 0.072 1 0.2 0.001 No statistical difference
4 B 0.5 0.05 0.040 0.65 0.15 0.029 No statistical difference
5 A 0.4 0 0.017 0.75 0 0.001 No statistical difference
6 S 1.45 0.1 0.000 1.55 0.75 0.000 No statistical difference
ACOUSTIC 
ANALYSIS
7 F0 205.44 207.28 0.840 134.08 160.21 0.001 No statistical difference
8 Shimmer 6.94 3.07 0.002 8.6 2.88 0.000 TVFMI® better
9 Jitter 1.84 0.49 0.004 2.33 0.377 0.000 Silastic implant better
10 MPT 2.55 6.45 0.000 2.6 6.85 0.000 No statistical difference
11 HNR 15.49 22.27 0.000 12.052 21.66 0.000 No statistical difference
12 NNE -4.46 -8.78 0.010 -3.018 -10.259 0.000 No statistical difference
EEG
13 F0 209.19 187.1 0.124 135.57 153.2 0.114 TVFMI®
14 Shimmer 8.94 3.23 0.002 9.19 1.76 0.000 TVFMI®
15 Jitter 1.89 0.61 0.001 2.016 0.48 0.000 No statistical difference
16 HNR 15.22 24.06 0.010 16.12 29.32 0.000 No statistical difference
17 NNE -12.29 -17.16 0.042 -13.63 -25.01 0.000 No statistical difference
18 CQ 67.34 66.08 0.725 70.33 96.67 0.390 No statistical difference
19 CQP 6.95 6.65 0.915 8.29 4.4 0.168 No statistical difference
and 55 minutes for TVFMI®.7 Other studies also reported 
shorter surgery times for TVFMI®. TVFMI® is pre-moulded, 
so that only its posterior limb needs to be adjusted, and 
it has been shown to be easier to insert and fix, thus redu-
cing the operative time.5,7-10 The present study used time 
compared to other studies in cases where silastic implant 
was inserted, because the silastic implant was moulded at 
the time of surgery. Keeping the silastic block pre-moulded 
may reduce the surgical time, as observed in other studies. 
TVFMI® is costlier than silastic implant and also requires a 
specialized tool (bending pliers) for insertion.
The improvement in quality of life scales, such as VHI, was 
observed in various studies.6,9 In the present study, a statistically 
significant post-operative improvement in VHI was observed with 
both silastic implant and TVFMI®. No statistically significant dif-
ference was observed between the improvements in the score of 
the two implants. Several studies have found the improvement 
in VHI to be a good indicator of voice improvement.11 
GRBAS is a well-known scale for perceptual assessment 
of voice.12 The voice of the patients improved post-opera-
tively, but it was still not normal. Perceptual analysis by 
GRBAS scale showed improvement. Breathiness, asthenia, 
and strain in voice were reduced, but roughness persisted 
post-operatively. Improvement in mean roughness score in 
patients treated with silastic implant was not found to be 
significant. Overall, the voice grading  improved with sur-
gery. Other studies7,9,10 have shown similar improvement 
in the perceptual scores post-operatively, even though the 
voice may still be rough and hoarse.
Endoscopic evaluation of vocal cord movement is an 
important tool.13 On videolaryngoscopic and stroboscopic 
examination, the glottic gap was found to be reduced in all 
but one case who underwent type I thyroplasty with silas-
tic implant. This was a case of idiopathic vocal cord palsy. 
During intra-operative fibreoptic laryngoscopic assessment, 
the glottic closure was found to be adequate; however, at 
follow-up, vocal cord atrophy was observed and the glottic 
gap reappeared. Mucosal wave pattern was not observed in 
any of the cases pre-operatively; post-operatively, it was 
present in 14 and 16 patients undergoing insertion of silastic 
implant and TVFMI®, respectively. Due to better glottic clo-
sure, the patients had a better voice quality  and could also 
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cough more effectively. Glottic gap closure was found to be 
reduced in 93% to 100% of cases following type I thyroplas-
ty.7,10 Storck et al. observed that TVFMI® pushes the entire 
cord medially, and hence gives better results. 
In the acoustic analysis and electroglottography, shim-
mer and jitter were reduced; maximum phonation time 
increased substantially, allowing patients to speak without 
voice breaks. HNR and NNE also improved, thus the hoar-
seness of voice decreased. There was improvement in the 
contact quotient of the vocal cords, and its perturbation 
decreased. The overall result was improved voice quality, 
as observed in several other studies.7-10 Jitter and shimmer 
percentage have been reported to improve after TVFMI® in-
sertion from 7.15 to 3.58 and from 27.8 to 13.69, respecti-
vely.8 Other studies have also observed statistically signifi-
cant improvements in jitter and shimmer .
On objective testing, TVFMI® presented superior results 
to silastic implant regarding to the following parameters: 
shimmer (acoustic and EGG) and F0 (EGG). Considering all 
the parameters, TVFMI® was better than silastic implant in 
only three. Better outcome with TVFMI® in these objective 
parameters may have been due to the case who had ina-
dequate glottic closure with silastic implant. In VHI, per-
ceptual rating of voice with GRBAS, and acoustic analysis 
and electroglottography, the voice improvement was statis-
tically similar with both types of implants. The medializa-
tion of vocal cords was adequate in both types of implants, 
and the glottic gap was adequately reduced in both. Other 
studieshave observed that TVFMI® presented a better voice 
outcome and shorter surgical duration.7-10 In the present 
study, the voice outcomes were similar between TVFMI® and 
silastic implant, except for the few abovementioned objec-
tive parameters. The case that presented inadequate glot-
tic closure with silastic implant may have been responsible 
for a slight bias in objective parameters towards TVFMI®.
Conclusion
This study has demonstrated that, in cases of unilateral vo-
cal cord palsy, there is a subjective improvement following 
type I thyroplasty using both silastic and TVFMI® implants 
(VHI and GRBAS). Videolaryngoscopy and stroboscopy de-
monstrated a reduction in glottic gap in all cases but one 
after surgery. TVFMI® presented slightly better result in ob-
jective voice analysis, but the impact of the case with per-
sistant glottic gap after medialization with silastic implant 
should be taken into consideration. Type I thyroplasty with 
TVFMI® is faster, but more expensive.
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